Invesco Small Cap Growth C (GTSDX)

20.56 +0.19  +0.93% May 29 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 20.56
Turnover Ratio 31.00%
1 Year Fund Level Flows -622.39M

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 9.77% 7.09% 20
3M 10.93% 3.53% 14
6M 4.01% -1.88% 25
YTD 2.73% -3.63% 24
1Y 13.34% 6.85% 26
3Y 9.17% 9.57% 49
5Y 7.39% 7.88% 59
10Y 12.16% 11.78% 48
15Y 8.85% 8.82% 57
20Y 5.98% 7.66% 84
As of May 29, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.65% 0.79% 0.14%
Stock 99.35% 99.35% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of March 31, 2020

Region Exposure

Americas 98.33%
North America 98.33%
Latin America 0.00%
Greater Europe 1.67%
United Kingdom 1.67%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.00%
% Emerging Markets 0.49%
As of March 31, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 2.71%
Communication Services 2.18%
Consumer Cyclical 11.36%
Consumer Defensive 3.24%
Energy 0.33%
Financial Services 5.92%
Healthcare 29.47%
Industrials 14.50%
Real Estate 2.22%
Technology 28.05%
Utilities 0.00%
As of March 31, 2020

Stock Market Capitalization

Giant 0.00%
Large 2.09%
Medium 63.04%
Small 34.50%
Micro 0.36%
As of March 31, 2020

Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 0.00%
Large Cap Growth 2.14%
Mid Cap Value 2.29%
Mid Cap Blend 15.90%
Mid Cap Growth 43.97%
Small Cap Value 3.13%
Small Cap Blend 8.44%
Small Cap Growth 24.14%
As of March 31, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
DXCM DexCom Inc 2.08% -- --
RGEN Repligen Corp 1.97% 130.50 -0.36%
EHTH eHealth Inc 1.80% -- --
CTLT Catalent Inc 1.70% 76.63 -1.42%
CHE Chemed Corp 1.68% 469.71 -1.84%
TECH Bio-Techne Corp 1.48% 262.01 -1.05%
QTWO Q2 Holdings Inc 1.41% 84.18 +1.89%
COR CoreSite Realty Corp 1.39% 125.10 +0.22%
RP RealPage Inc 1.24% 68.64 +1.21%
MASI Masimo Corp 1.21% 236.95 -1.35%
As of March 31, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks long-term growth of capital. The fund invests, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of small-capitalization issuers. It invests primarily in equity securities. The principal type of equity security in which the fund invests is common stock. The fund's manager considers an issuer to be a small-capitalization issuer if it has a market capitalization, at the time of purchase, no larger than the largest capitalized issuer included in the Russell 2000® Index.
General
Security Type Mutual Fund
Oldest Share Symbol GTSAX
Equity Style Mid Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Small Growth
Prospectus Objective Small Company
Fund Owner Firm Name Invesco
Benchmark Index
Russell 2000 Growth TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Clay Manley 12.01 yrs
Juan Hartsfield 15.65 yrs
Justin Sander 0.00 yrs

Share Classes

Symbol Share Class
GTSAX A
GTSFX Retirement
GTSIX Inv
GTSRX Retirement
GTSVX Retirement
GTSYX Inst

Net Fund Flows

1M -64.05M
3M -165.35M
6M -352.38M
YTD -286.30M
1Y -622.39M
3Y -770.12M
5Y -1.027B
10Y -1.466B
As of May 31, 2020

Risk Info

Beta (5Y) 1.224
Historical Sharpe Ratio (10Y) 0.6941
Historical Sortino (All) 0.6036
Daily Value at Risk (VaR) 1% (All) 4.20%
Monthly Value at Risk (VaR) 1% (All) 19.76%

Fundamentals

Dividend Yield TTM (5-29-20) 0.00%
30-Day SEC Yield --
7-Day SEC Yield (5-28-20) 0.00%
Weighted Average PE Ratio 25.19
Weighted Average Price to Sales Ratio 2.145
Weighted Average Price to Book Ratio 3.578
Weighted Median ROE 9.60%
Weighted Median ROA 2.94%
Forecasted Dividend Yield 0.64%
Forecasted PE Ratio 22.04
Forecasted Price to Sales Ratio 1.946
Forecasted Price to Book Ratio 3.099
Number of Holdings 134
As of March 31, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 12.09%
Forecasted Book Value Growth 11.88%
Forecasted Cash Flow Growth 11.09%
Forecasted Earnings Growth 9.65%
Forecasted Revenue Growth 7.52%
As of March 31, 2020

Comparables

Edit

Attributes

Purchase Details
Open to New Investors No
Open to Existing Investors Yes
Minimum Initial Investment 1000.00 USD
Minimum Subsequent Investment 50.00 USD
Fees
Actual 12B-1 Fee 1.00%
Actual Management Fee 0.68%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load 1.00%
Maximum Redemption Fee --
Key Dates
Inception Date 5/3/1999
Termination Date
Last Annual Report Date 12/31/2019
Last Prospectus Date 4/30/2020
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.